CSIMarket


Moderna Inc   (MRNA)
Other Ticker:  
 

Moderna Inc 's Leverage Ratio

MRNA's quarterly Leverage Ratio and Total Liabilities, Equity growth




MRNA Leverage Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity Change 266.84 % 127.49 % 133.9 % - -
Y / Y Total Liabilities Change 469.17 % 1632.92 % 1977.12 % 46231.38 % 12910.55 %
Leverage Ratio MRQ 1.07 1.41 2.31 1.86 0.69
Overall Ranking # # # # #
Seq. Equity Change 51.01 % 74.67 % 49.84 % -7.19 % -6.35 %
Seq. Total Liabilities Change 14.29 % 6.62 % 85.59 % 151.69 % 247.97 %



Leverage Ratio third quarter 2021 Comment
Despite net new borrowings of 14.29% Moderna Inc managed to improve Leverage Ratio in the third quarter 2021 to 1.07, below company's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2021, 162 other companies have achieved lower Leverage Ratio than Moderna Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are MRNA Customers?
Leverage Ratio third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 163
Healthcare Sector # 669
Overall Market # 2000


Leverage Ratio Statistics
High Average Low
216.5 13.93 0.19
(Dec 31 2011)   (Jun 30 2020)




Financial Statements
Moderna Inc 's Equity $ 10,124 Millions Visit MRNA's Balance sheet
Moderna Inc 's Total Liabilities $ 10,799 Millions Visit MRNA's Balance sheet
Source of MRNA's Sales Visit MRNA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2021, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2021 MRQ Total LiabilitiesSep 30 2021 MRQ Equity
Codiak Biosciences Inc   2.58 $ 87.617  Millions$ 34.006  Millions
Evelo Biosciences Inc   2.46 $ 81.505  Millions$ 33.076  Millions
Cytomx Therapeutics Inc   2.32 $ 259.559  Millions$ 111.674  Millions
Axim Biotechnologies Inc   2.07 $ 9.600  Millions$ 4.648  Millions
Brooklyn Immunotherapeutics Inc   1.99 $ 25.946  Millions$ 13.040  Millions
Surgalign Holdings Inc   1.98 $ 93.145  Millions$ 47.111  Millions
Acorda Therapeutics inc   1.83 $ 301.612  Millions$ 164.475  Millions
Reynolds Consumer Products Inc   1.79 $ 3,039.000  Millions$ 1,694.000  Millions
Avantor Inc   1.77 $ 7,272.900  Millions$ 4,104.800  Millions
Gilead Sciences Inc   1.75 $ 37,657.000  Millions$ 21,471.000  Millions
Infinity Pharmaceuticals Inc   1.62 $ 51.925  Millions$ 32.144  Millions
Iteos Therapeutics Inc   1.48 $ 550.340  Millions$ 372.039  Millions
Nanostring Technologies Inc   1.48 $ 294.265  Millions$ 199.119  Millions
Establishment Labs Holdings Inc   1.38 $ 84.832  Millions$ 61.560  Millions
Wave Life Sciences Ltd   1.36 $ 40.528  Millions$ 29.901  Millions
Cure Pharmaceutical Holding Corp   1.34 $ 24.944  Millions$ 18.585  Millions
Gossamer Bio Inc   1.28 $ 217.229  Millions$ 169.809  Millions
Adma Biologics Inc   1.25 $ 128.300  Millions$ 102.780  Millions
Biogen Inc   1.23 $ 13,376.800  Millions$ 10,881.700  Millions
Phathom Pharmaceuticals Inc   1.19 $ 123.616  Millions$ 103.481  Millions
Unity Biotechnology Inc   1.18 $ 67.954  Millions$ 57.737  Millions
Royalty Pharma Plc  1.14 $ 11,829.288  Millions$ 10,386.634  Millions
Cv Sciences Inc   1.10 $ 12.311  Millions$ 11.142  Millions
Moderna Inc   1.07 $ 10,799.000  Millions$ 10,124.000  Millions
Aytu Biopharma inc   1.04 $ 116.229  Millions$ 111.500  Millions
Axcella Health Inc   0.94 $ 33.260  Millions$ 35.561  Millions
Sangamo Therapeutics Inc   0.90 $ 366.382  Millions$ 406.016  Millions
Emergent Biosolutions Inc   0.88 $ 1,344.800  Millions$ 1,522.700  Millions
Regenxbio Inc   0.73 $ 338.981  Millions$ 461.414  Millions
Merus N v   0.73 $ 150.158  Millions$ 205.769  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MPAC's Profile

Stock Price

MPAC's Financials

Business Description

Fundamentals

Charts & Quotes

MPAC's News

Suppliers

MPAC's Competitors

Customers & Markets

Economic Indicators

MPAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071